Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients.

Kamar N, Milioto O, Puissant-Lubrano B, Esposito L, Pierre MC, Mohamed AO, Lavayssière L, Cointault O, Ribes D, Cardeau I, Nogier MB, Durand D, Abbal M, Blancher A, Rostaing L.

Am J Transplant. 2010 Jan;10(1):89-98. doi: 10.1111/j.1600-6143.2009.02785.x. Epub 2009 Jul 28.

PMID:
19656128
[PubMed - indexed for MEDLINE]
Free Article
2.

Comparison of daclizumab, an interleukin 2 receptor antibody, to anti-thymocyte globulin-Fresenius induction therapy in kidney transplantation.

Abou-Jaoude MM, Ghantous I, Almawi WY.

Mol Immunol. 2003 Jul;39(17-18):1083-8.

PMID:
12835081
[PubMed - indexed for MEDLINE]
3.

Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.

Wasson S, Zafar MN, Best J, Reddy HK.

J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):77-83.

PMID:
16703222
[PubMed - indexed for MEDLINE]
4.

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D; Thymoglobulin Induction Study Group.

N Engl J Med. 2006 Nov 9;355(19):1967-77.

PMID:
17093248
[PubMed - indexed for MEDLINE]
Free Article
5.

Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapy.

Nishida H, Ishida H, Tanaka T, Amano H, Omoto K, Shirakawa H, Shimizu T, Iida S, Toki D, Yamaguchi Y, Tanabe K.

Transpl Int. 2009 Oct;22(10):961-9. doi: 10.1111/j.1432-2277.2009.00903.x. Epub 2009 Jul 10.

PMID:
19619177
[PubMed - indexed for MEDLINE]
6.

Intraoperative anti-thymocyte globulin-Fresenius (ATG-F) administration as induction immunosuppressive therapy in kidney transplantation.

Abou-Jaoude MM, Almawi WY.

Mol Immunol. 2003 Jul;39(17-18):1089-94.

PMID:
12835082
[PubMed - indexed for MEDLINE]
7.

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.

Milpied N, Vasseur B, Parquet N, Garnier JL, Antoine C, Quartier P, Carret AS, Bouscary D, Faye A, Bourbigot B, Reguerre Y, Stoppa AM, Bourquard P, Hurault de Ligny B, Dubief F, Mathieu-Boue A, Leblond V.

Ann Oncol. 2000;11 Suppl 1:113-6.

PMID:
10707791
[PubMed - indexed for MEDLINE]
8.

Evaluation of low-dose rituximab induction therapy in living related kidney transplantation.

Takagi T, Ishida H, Shirakawa H, Shimizu T, Tanabe K.

Transplantation. 2010 Jun 27;89(12):1466-70. doi: 10.1097/TP.0b013e3181dc0999. Erratum in: Transplantation. 2010 Sep 15;90(5):589.

PMID:
20559108
[PubMed - indexed for MEDLINE]
9.

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP.

Lancet. 1997 Oct 25;350(9086):1193-8. Erratum in: Lancet 1997 Nov 15;350(9089):1484.

PMID:
9652559
[PubMed - indexed for MEDLINE]
10.

Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin's lymphoma patients receiving autologous hematopoietic stem cell transplantation.

Lee MY, Chiou TJ, Hsiao LT, Yang MH, Lin PC, Poh SB, Yen CC, Liu JH, Teng HW, Chao TC, Wang WS, Chen PM.

Ann Hematol. 2008 Apr;87(4):285-9. Epub 2007 Oct 18.

PMID:
17943285
[PubMed - indexed for MEDLINE]
11.

Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation.

Clark G, Walsh G, Deshpande P, Koffman G.

Nephrol Dial Transplant. 2002 Jul;17(7):1304-9.

PMID:
12105256
[PubMed - indexed for MEDLINE]
Free Article
12.

Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody.

Peleg AY, Husain S, Kwak EJ, Silveira FP, Ndirangu M, Tran J, Shutt KA, Shapiro R, Thai N, Abu-Elmagd K, McCurry KR, Marcos A, Paterson DL.

Clin Infect Dis. 2007 Jan 15;44(2):204-12. Epub 2006 Dec 13.

PMID:
17173218
[PubMed - indexed for MEDLINE]
Free Article
13.

Infectious complications after simultaneous pancreas-kidney transplantation.

Michalak G, Kwiatkowski A, Bieniasz M, Meszaros J, Czerwinski J, Wszola M, Nosek R, Ostrowski K, Chmura A, Danielewicz R, Lisik W, Adadynski L, Fesołowicz S, Dobrowolska A, Durlik M, Rowiñski W.

Transplant Proc. 2005 Oct;37(8):3560-3.

PMID:
16298661
[PubMed - indexed for MEDLINE]
14.

Hepatitis C virus infection and rituximab therapy after renal transplantation.

Fabrizi F, Martin P, Elli A, Montagnino G, Banfi G, Passerini P, Campise MR, Tarantino A, Ponticelli C.

Int J Artif Organs. 2007 May;30(5):445-9.

PMID:
17551909
[PubMed - indexed for MEDLINE]
15.

Safety of rituximab in rheumatoid arthritis patients with a history of severe or recurrent bacterial infection: observational study of 30 cases in everyday practice.

Toussirot E, Pertuiset E, Sordet C, Augé B, Wendling D, Pallot-Pradès B, Collet P, Lohse A, Balblanc JC.

Joint Bone Spine. 2010 Mar;77(2):142-5. doi: 10.1016/j.jbspin.2010.01.008. Epub 2010 Feb 19.

PMID:
20171921
[PubMed - indexed for MEDLINE]
16.

Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.

Sollinger H, Kaplan B, Pescovitz MD, Philosophe B, Roza A, Brayman K, Somberg K.

Transplantation. 2001 Dec 27;72(12):1915-9.

PMID:
11773888
[PubMed - indexed for MEDLINE]
17.

Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution.

Saavedra S, Jarque I, Sanz GF, Moscardó F, Jiménez C, Martín G, Plumé G, Regadera A, Martínez J, De La Rubia J, Acosta B, Pemán J, Pérez-Bellés C, Gobernado M, Sanz MA.

Clin Microbiol Infect. 2002 Nov;8(11):725-33.

PMID:
12445010
[PubMed - indexed for MEDLINE]
18.

Incidence of infectious complications in highly sensitized renal transplant recipients treated by rituximab: a case-controlled study.

Scemla A, Loupy A, Candon S, Mamzer MF, Martinez F, Zuber J, Sberro R, Legendre C, Thervet E.

Transplantation. 2010 Dec 15;90(11):1180-4. doi: 10.1097/TP.0b013e3181fa941b.

PMID:
20885337
[PubMed - indexed for MEDLINE]
19.

Combined use of rituximab and plasmapheresis pre-transplant increases post-transplant infections in renal transplant recipients with basiliximab induction therapy.

Chung BH, Yun JT, Ha SE, Kim JI, Moon IS, Choi BS, Park CW, Kim YS, Yang CW.

Transpl Infect Dis. 2013 Dec;15(6):559-68. doi: 10.1111/tid.12135. Epub 2013 Sep 9.

PMID:
24011062
[PubMed - indexed for MEDLINE]
20.

Infection after heart transplantation: a multiinstitutional study. Cardiac Transplant Research Database Group.

Miller LW, Naftel DC, Bourge RC, Kirklin JK, Brozena SC, Jarcho J, Hobbs RE, Mills RM.

J Heart Lung Transplant. 1994 May-Jun;13(3):381-92; discussion 393.

PMID:
8061013
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk